|
?:reviewBody
|
-
On 11 June 2015, the Facebook page Pet Helpers published a post warning dog owners about the purported dangers of BRAVECTO chewable flea and tick remedy: According to that post, a pet-owning family had seen one of their pets die within a day of being given BRAVECTO chewables, and that another of their dogs had nearly died after being given the same treatment at the same time. The post also asserted that BRAVECTO chewables were cause of death in several other dogs who had died of liver and kidney failure shortly after taking the same medication. Bravecto (fluralaner) is a systemic antiparasitic drug introduced to the veterinary market by Merck in 2014. A 7 March 2014 study published in the journal Parasites & Vectors (based upon a study of 32 beagles treated with fluralaner) observed no serious adverse side effects attributed to the medication: A 15 May 2014 Freedom of Information Summary [PDF] published on the Food and Drug Administration's (FDA) web site reiterated the results of that study: As the BRAVECTO social media warning spread among dog owners, the Wilson Street Veterinary Facebook page published a response addressing rumors about the drug's safety. In that post, Dr. Michael Mogavero stated that the drug had been extensively tested prior to its release and had proved safe for dogs: In September 2018, the FDA issued a safety communication advising consumers of reports of adverse events in dogs and cats treated with Bravecto and similar products, while noting that these products continue to be safe and effective for the majority of animals:
(en)
|
![[This page as RDF]](http://data.gesis.org/claimskg/static/rdf-icon.gif){kind=icon}